Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA609932
Max Phase: Preclinical
Molecular Formula: C37H68O9
Molecular Weight: 656.94
Molecule Type: Small molecule
Associated Items:
ID: ALA609932
Max Phase: Preclinical
Molecular Formula: C37H68O9
Molecular Weight: 656.94
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCC[C@H](O)[C@H]1CC[C@@H]([C@@H]2CC[C@H]([C@H](O)CCCCCCCCCC[C@@H](O)C[C@]3(O)C(=O)O[C@@H](C)[C@H]3O)O2)O1
Standard InChI: InChI=1S/C37H68O9/c1-3-4-5-6-7-11-14-17-20-29(39)31-22-24-33(45-31)34-25-23-32(46-34)30(40)21-18-15-12-9-8-10-13-16-19-28(38)26-37(43)35(41)27(2)44-36(37)42/h27-35,38-41,43H,3-26H2,1-2H3/t27-,28+,29-,30+,31+,32+,33-,34-,35+,37+/m0/s1
Standard InChI Key: SSGYQQLEDZKXBD-BCKGADQASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 656.94 | Molecular Weight (Monoisotopic): 656.4863 | AlogP: 6.02 | #Rotatable Bonds: 25 |
Polar Surface Area: 145.91 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.29 | CX Basic pKa: | CX LogP: 6.70 | CX LogD: 6.70 |
Aromatic Rings: 0 | Heavy Atoms: 46 | QED Weighted: 0.06 | Np Likeness Score: 1.45 |
1. Tormo JR, Estornell E, Gallardo T, González MC, Cavé A, Granell S, Cortes D, Zafra-Polo MC.. (2001) Gamma-lactone-Functionalized antitumoral acetogenins are the most potent inhibitors of mitochondrial complex I., 11 (5): [PMID:11266168] [10.1016/s0960-894x(01)00036-1] |
Source(1):